Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases

Highlights:  - Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor. - A symposium was held bringing together stakeholders on this issue, including from academia, government and NGOs. -...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Ruth, Murphy, Adrianna, Bygrave, Helen, Ansbro, Éimhín, Grobbee, Diederick E., Perel, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Editorial Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442173/
https://www.ncbi.nlm.nih.gov/pubmed/32923350
http://dx.doi.org/10.5334/gh.860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442173/
https://www.ncbi.nlm.nih.gov/pubmed/32923350
http://dx.doi.org/10.5334/gh.860

Ejemplares similares